Evidence map›Paper›PMID 33177189›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2020

Niilo Kaldalu, Vasili Hauryliuk, Kathryn Jane Turnbull, Agnese La Mensa, Marta Putrinš, Tanel Tenson

Open access · greenAbstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Association ofPathogens (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. A link between aging and persistence.Antimicrobial agents and chemotherapy · 2025
    Article
  9. Article
  10. Mini review: Persister cell control strategies.Frontiers in pharmacology · 2025
    Review
  11. Review
  12. Article
  13. HNature communications · 2024
    Article
  14. Article
  15. Ultrasound-Mediated Antibiotic Delivery to In Vivo Biofilm Infections: A Review.Chembiochem : a European journal of chemical biology · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Niilo KaldaluInstitute of Technology, University of Tartu, Tartu, Estonia niilo.kaldalu@ut.ee.ORCID 0000-0002-1457-2291
Vasili HauryliukInstitute of Technology, University of Tartu, Tartu, Estonia.ORCID 0000-0003-2389-5057
Kathryn Jane TurnbullDepartment of Molecular Biology, Umeå University, Umeå, Sweden.ORCID 0000-0002-0899-974X
Agnese La MensaInstitute of Technology, University of Tartu, Tartu, Estonia.
Marta PutrinšInstitute of Technology, University of Tartu, Tartu, Estonia.ORCID 0000-0003-1492-2826
Tanel TensonInstitute of Technology, University of Tartu, Tartu, Estonia.ORCID 0000-0002-0260-3601
University of Tartu · EEUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many bacterial pathogens can permanently colonize their host and establish either chronic or recurrent infections that the immune system and antimicrobial therapies fail to eradicate. Antibiotic persisters (persister cells) are believed to be among the factors that make these infections challenging. Persisters are subpopulations of bacteria which survive treatment with bactericidal antibiotics in otherwise antibiotic-sensitive cultures and were extensively studied in a hope to discover the mechanisms that cause treatment failures in chronically infected patients; however, most of these studies were conducted in the test tube. Research into antibiotic persistence has uncovered large intrapopulation heterogeneity of bacterial growth and regrowth but has not identified essential, dedicated molecular mechanisms of antibiotic persistence. Diverse factors and stresses that inhibit bacterial growth reduce killing of the bulk population and may also increase the persister subpopulation, implying that an array of mechanisms are present. Hopefully, further studies under conditions that simulate the key aspects of persistent infections will lead to identifying target mechanisms for effective therapeutic solutions.

Indexed as

AnimalsAnti-Bacterial AgentsBacteriaBacterial InfectionsDrug Resistance, Multiple, BacterialHost-Pathogen InteractionsHumansMicrobial ViabilityAnti-Bacterial Agentsantibiotic resistanceantimicrobial agentspersistence

Identifiers

PMID33177189
PMCPMC7667008
OpenAlexW3098882283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.